Zongsheng He
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Zongsheng He has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
- Bin Wang
Department of Gastroenterology, Chongqing Key Laboratory of Digestive Malignancies, Daping Hospital, Chongqing, China
3 shared publications Qin Liu
Department of Gastroenterology & Chongqing Key Laboratory of Digestive Malignancies, Daping Hospital, Army Medical University (Third Military Medical University), 10# Changjiang Branch Road, Yuzhong District, Chongqing, 400042, PR China; Institute of Pathology and Southwest Cancer Center, and Key Laboratory of Tumor Immunopathology of Ministry of Education of China, Southwest Hospital, Army Medical University (Third Military Medical University), Chongqing, 400038, PR China
2 shared publications- Bo Tang
Department of General Surgery, The First Affiliated Hospital (Southwest Hospital) of Army Medical University (Third Military Medical University), Chongqing, 400038, People's Republic of China.
1 shared publication Dongfeng Chen
Department of Gastroenterology, Chongqing Key Laboratory of Digestive Malignancies, Daping Hospital, Army Medical University (Third Military Medical University), Chongqing, 400042, China
1 shared publicationFei Xiang
Institute of Burn Research, Southwest Hospital, Army Medical University (Third Military Medical University), Chongqing, 400038, PR China
1 shared publicationHongyang Yu
Department of Gastroenterology, Chongqing Key Laboratory of Digestive Malignancies, Daping Hospital, Army Medical University (Third Military Medical University), Chongqing, 400042, China
1 shared publication
Latest Publications
- Top Cited PapersOpen Access
- 2 March 2026
- Published by Springer Nature in Molecular Cancer
- Vol. 25 (1)
Artificial intelligence models: transforming early diagnosis and precise treatment of gastrointestinal cancers
Artificial intelligence (AI) has become an integral force in the clinical landscape of gastrointestinal (GI) oncology. Recent advances in model architectures ranging from traditional machine learning and convolutional neural networks (CNNs) to transformer-based foundational models and graph neural networks (GNNs) have enabled the extraction of complex features from diverse data modalities, including endoscopic images, radiology, pathology whole-slide images, and multi-omics profiles. In this review, AI models are systematically classified into supervised learning, unsupervised clustering, multimodal fusion, and interpretable modeling. The advantages of each model are delineated in unravelling tumor heterogeneity, anatomical characteristics, and treatment-relevant biomarkers. Furthermore, three types of clinical application are emphasized: (1) early screening and lesion localization via segmentation or anomaly detection; (2) molecular subtyping and patient stratification for diagnosis with risk assessment; (3) therapy guidance through response prediction and personalized treatment planning. We also discuss major challenges on the application of AI in integration of heterogeneous clinical data, model generalizability across centers, and the interpretability of predictions. Collectively, this review highlights the transformative potential of AI in better understanding tumor biology and its clinical value in advancing personalized medicine for GI cancer patients.
- 2 March 2026
- Published by Springer Nature in Molecular Cancer
- Vol. 25 (1)
Top Cited PapersOpen AccessArtificial intelligence models: transforming early diagnosis and precise treatment of gastrointestinal cancers
Artificial intelligence (AI) has become an integral force in the clinical landscape of gastrointestinal (GI) oncology. Recent advances in model architectures ranging from traditional machine learning and convolutional neural networks (CNNs) to transformer-based foundational models and graph neural networks (GNNs) have enabled the extraction of complex features from diverse data modalities, including endoscopic images, radiology, pathology whole-slide images, and multi-omics profiles. In this review, AI models are systematically classified into supervised learning, unsupervised clustering, multimodal fusion, and interpretable modeling. The advantages of each model are delineated in unravelling tumor heterogeneity, anatomical characteristics, and treatment-relevant biomarkers. Furthermore, three types of clinical application are emphasized: (1) early screening and lesion localization via segmentation or anomaly detection; (2) molecular subtyping and patient stratification for diagnosis with risk assessment; (3) therapy guidance through response prediction and personalized treatment planning. We also discuss major challenges on the application of AI in integration of heterogeneous clinical data, model generalizability across centers, and the interpretability of predictions. Collectively, this review highlights the transformative potential of AI in better understanding tumor biology and its clinical value in advancing personalized medicine for GI cancer patients.
- 25 February 2025
- Published by Elsevier in Cancer Letters
- Vol. 616, 217589
Neural-cancer crosstalk: Reciprocal molecular circuits driving gastric tumorigenesis and emerging therapeutic opportunities
- 25 February 2025
- Published by Elsevier in Cancer Letters
- Vol. 616, 217589
Neural-cancer crosstalk: Reciprocal molecular circuits driving gastric tumorigenesis and emerging therapeutic opportunities
- 6 December 2024
- Published by Elsevier in Cancer Letters
- Vol. 611, 217385
Tumor microenvironment: Nurturing cancer cells for immunoevasion and druggable vulnerabilities for cancer immunotherapy
- 6 December 2024
- Published by Elsevier in Cancer Letters
- Vol. 611, 217385
Tumor microenvironment: Nurturing cancer cells for immunoevasion and druggable vulnerabilities for cancer immunotherapy